Inventor · disambiguated record
Vicente Samano
Also filed as: SAMANO VICENTE
19 granted patents·7 pending applications·123 citations·filing 1996–2023
91Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD9VERTEX PHARMA6GLAXO WELLCOME INC2GLAXOSMITHKLINE IP NO 2 LTD2SMITHKLINE BEECHAM CORP2
Top patents by PatentIndex Score
26 records- 0197US6319946B1Inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 2000·Granted Nov 20, 2001·88 cites·22 claims
- 0288US10358427B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 23, 2019·11 cites·8 claims
- 0382US2024182473A1Compounds useful in hiv therapyGLAXOSMITHKLINE IP DEV LTD·Filed 2023·Application pending·0 cites
- 0476US8455497B2Inhibitors of aspartyl proteaseHALE MICHAEL R·Filed 2009·Granted Jun 4, 2013·2 cites·40 claims
- 0574US6617350B2Inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 2001·Granted Sep 9, 2003·5 cites·22 claims
- 0672US6878728B1Inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 2000·Granted Apr 12, 2005·7 cites·20 claims
- 0770US8609653B2Azaindole compounds and methods for treating HIVDE LA ROSA MARTHA ALICIA·Filed 2012·Granted Dec 17, 2013·3 cites·11 claims
- 0870US7442833B2Triphenylethylene compounds as selective estrogen receptor modulatorsSMITHKLINE BEECHAM CORP·Filed 2004·Granted Oct 28, 2008·6 cites·21 claims
- 0969US2022411425A1Compounds useful in hiv therapyGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 1064US9163023B2Compounds and methods for treating HIVVIIV HEALTHCARE UK LTD·Filed 2013·Granted Oct 20, 2015·1 cites·17 claims
- 1162US7919523B2Inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 2008·Granted Apr 5, 2011·0 cites·20 claims
- 1257US10899754B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jan 26, 2021·0 cites·5 claims
- 1355US7442718B2Inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 2003·Granted Oct 28, 2008·0 cites·15 claims
- 1452US2009170906A1Hcv inhibitorsGUDMUNDSSON KRISTJAN·Filed 2005·Application pending·0 cites
- 1551US10906924B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Feb 2, 2021·0 cites·17 claims
- 1649US10787442B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Sep 29, 2020·0 cites·2 claims
- 1748US2011118261A1Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonistsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 1848US2022259252A14'-ethynyl-2'-deoxyadenosine derivatives and their use in hiv therapyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Application pending·0 cites
- 1947US2004122000A1Inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 2003·Application pending·0 cites
- 2045US10239894B2Inhibitors of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 26, 2019·0 cites·7 claims
- 2143US10472336B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Nov 12, 2019·0 cites·11 claims
- 2242US10538495B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jan 21, 2020·0 cites·2 claims
- 2342US7402606B2Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone lossSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jul 22, 2008·0 cites·46 claims
- 2438US2021078988A1Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 2527US6143748AProcess for synthesis of nucleoside analoguesGLAXO WELLCOME INC·Filed 1996·Granted Nov 7, 2000·0 cites·15 claims
- 2627US6066733A4-ethoxy-pyrimidinesGLAXO WELLCOME INC·Filed 1999·Granted May 23, 2000·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →